Firstly, the expression of LIS1 in CD133+ CSC population isolated from tumor cell lines and primary cultures of breast cancer, lung cancer, melanoma, and colorectal cancer should be evaluated. This evidence concerns the gene PAFAH1B1 and breast cancer.